Single and Multiple Dose Pharmacokinetics of Maraviroc in Saliva, Semen, and Rectal Tissue of Healthy HIV-Negative Men

HIV-1 Vaccine Development After STEP

(2010) Dan H. Barouch et al.   Annual Review of Medicine

Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women

(2010) Q. Abdool Karim et al.   SCIENCE

Microbicides for HIV prevention: reality or hope?

(2009) Ian McGowan   CURRENT OPINION IN INFECTIOUS DISEASES

Maraviroc Concentrates in the Cervicovaginal Fluid and Vaginal Tissue of HIV-Negative Women

(2009) Julie B Dumond et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Assessment of the pharmacokinetics, safety and tolerability of maraviroc, a novel CCR5 antagonist, in healthy volunteers

(2008) Samantha Abel et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Rectal microbicides: a new focus for HIV prevention

(2008) I McGowan   SEXUALLY TRANSMITTED INFECTIONS

Preclinical assessment of the distribution of maraviroc to potential human immunodeficiency virus (HIV) sanctuary sites in the central nervous system (CNS) and gut-associated lymphoid tissue (GALT)

(2008) D. K. Walker et al.   XENOBIOTICA